Larimar Therapeutics Inc. (ZA71)
Market Closed
3 Jun, 20:00
XFRA 
€
2. 8000
-0.16
-5.41%
€
- Market Cap
- P/E Ratio
- Div Yield
7,666 Volume
-1.23 Eps
€ 2.96
Previous Close Want to track ZA71 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ZA71 Earnings Reports FAQ
What is the earnings per share (EPS) for ZA71?
The current EPS is -1.23.
What is the company's earnings growth rate?
Larimar Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Larimar Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Larimar Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ZA71 at this time, as Larimar Therapeutics Inc has no recent EPS data to calculate it.
